CLEARONE INC (CLRO) Fundamental Analysis & Valuation

NASDAQ:CLRO • US18506U2033

4.55 USD
-0.02 (-0.44%)
Last: Mar 6, 2026, 07:08 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CLRO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

Taking everything into account, CLRO scores 2 out of 10 in our fundamental rating. CLRO was compared to 48 industry peers in the Communications Equipment industry. The financial health of CLRO is average, but there are quite some concerns on its profitability. CLRO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. CLRO Profitability Analysis

1.1 Basic Checks

  • CLRO had negative earnings in the past year.
  • In the past year CLRO has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: CLRO reported negative net income in multiple years.
  • In the past 5 years CLRO reported 4 times negative operating cash flow.
CLRO Yearly Net Income VS EBIT VS OCF VS FCFCLRO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

  • With a Return On Assets value of -246.44%, CLRO is not doing good in the industry: 95.83% of the companies in the same industry are doing better.
  • Looking at the Return On Equity, with a value of -553.33%, CLRO is doing worse than 89.58% of the companies in the same industry.
Industry RankSector Rank
ROA -246.44%
ROE -553.33%
ROIC N/A
ROA(3y)-3.47%
ROA(5y)-4.24%
ROE(3y)-5.21%
ROE(5y)-5.91%
ROIC(3y)N/A
ROIC(5y)N/A
CLRO Yearly ROA, ROE, ROICCLRO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

  • CLRO has a worse Gross Margin (10.42%) than 93.75% of its industry peers.
  • CLRO's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for CLRO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.52%
GM growth 5Y-12.37%
CLRO Yearly Profit, Operating, Gross MarginsCLRO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. CLRO Health Analysis

2.1 Basic Checks

  • CLRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CLRO remains at a similar level compared to 1 year ago.
  • CLRO has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for CLRO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CLRO Yearly Shares OutstandingCLRO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
CLRO Yearly Total Debt VS Total AssetsCLRO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • Based on the Altman-Z score of -5.76, we must say that CLRO is in the distress zone and has some risk of bankruptcy.
  • CLRO has a worse Altman-Z score (-5.76) than 75.00% of its industry peers.
  • CLRO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.76
ROIC/WACCN/A
WACC9.61%
CLRO Yearly LT Debt VS Equity VS FCFCLRO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 2.29 indicates that CLRO has no problem at all paying its short term obligations.
  • CLRO has a Current ratio (2.29) which is comparable to the rest of the industry.
  • CLRO has a Quick Ratio of 2.19. This indicates that CLRO is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of CLRO (2.19) is better than 72.92% of its industry peers.
Industry RankSector Rank
Current Ratio 2.29
Quick Ratio 2.19
CLRO Yearly Current Assets VS Current LiabilitesCLRO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. CLRO Growth Analysis

3.1 Past

  • CLRO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -429.02%.
  • CLRO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -42.90%.
  • CLRO shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -14.58% yearly.
EPS 1Y (TTM)-429.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-513.95%
Revenue 1Y (TTM)-42.9%
Revenue growth 3Y-26.75%
Revenue growth 5Y-14.58%
Sales Q2Q%-100%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CLRO Yearly Revenue VS EstimatesCLRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CLRO Yearly EPS VS EstimatesCLRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 0 5 10

More info and screens

Find the best growth stocksShow best growing peers

0

4. CLRO Valuation Analysis

4.1 Price/Earnings Ratio

  • CLRO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLRO Price Earnings VS Forward Price EarningsCLRO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CLRO Per share dataCLRO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CLRO Dividend Analysis

5.1 Amount

  • No dividends for CLRO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CLRO Fundamentals: All Metrics, Ratios and Statistics

CLEARONE INC

NASDAQ:CLRO (3/6/2026, 7:08:42 PM)

4.55

-0.02 (-0.44%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)11-13
Earnings (Next)03-30
Inst Owners2.06%
Inst Owner Change125.08%
Ins Owners0.13%
Ins Owner Change-27.72%
Market Cap10.19M
Revenue(TTM)7.18M
Net Income(TTM)-23.34M
Analysts85.71
Price TargetN/A
Short Float %1.49%
Short Ratio1.21
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend9.07
Dividend Growth(5Y)113.94%
DP-2.12%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.42
P/FCF N/A
P/OCF N/A
P/B 2.42
P/tB 2.42
EV/EBITDA N/A
EPS(TTM)-13.65
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-3.33
FCFYN/A
OCF(TTM)-3.28
OCFYN/A
SpS3.21
BVpS1.88
TBVpS1.88
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -246.44%
ROE -553.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.42%
FCFM N/A
ROA(3y)-3.47%
ROA(5y)-4.24%
ROE(3y)-5.21%
ROE(5y)-5.91%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.52%
GM growth 5Y-12.37%
F-Score3
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20.41%
Cap/Sales 1.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.29
Quick Ratio 2.19
Altman-Z -5.76
F-Score3
WACC9.61%
ROIC/WACCN/A
Cap/Depr(3y)41.23%
Cap/Depr(5y)32.53%
Cap/Sales(3y)2.06%
Cap/Sales(5y)1.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-429.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-513.95%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-42.9%
Revenue growth 3Y-26.75%
Revenue growth 5Y-14.58%
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-115.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-115%
OCF growth 3YN/A
OCF growth 5YN/A

CLEARONE INC / CLRO FAQ

What is the ChartMill fundamental rating of CLEARONE INC (CLRO) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CLRO.


What is the valuation status of CLEARONE INC (CLRO) stock?

ChartMill assigns a valuation rating of 0 / 10 to CLEARONE INC (CLRO). This can be considered as Overvalued.


Can you provide the profitability details for CLEARONE INC?

CLEARONE INC (CLRO) has a profitability rating of 0 / 10.


Can you provide the financial health for CLRO stock?

The financial health rating of CLEARONE INC (CLRO) is 6 / 10.